Oxford BioMedica PLC H1 Net Loss Narrows, CEO Leaves
LONDON, Aug 29 (Reuters) - Oxford Biomedica Plc , the British biotech company, reported a net cash position at its half-time point of 27 million pounds ($49.4 million) compared with 42.5 million last year.